The Effect of COVID-19 on Diabetes Mellitus

The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04592055

Acronym

COVID-19-DM

Enrollment

500

Registered

2020-10-19

Start date

2020-03-20

Completion date

2021-07-01

Last updated

2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Diabetes Mellitus

Brief summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Detailed description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

\- All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

Exclusion criteria

\- The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Design outcomes

Primary

Measure	Time frame	Description
A1c	6 months (3 months before and after COVID-19	the change in A1c levels

Countries

Turkey (Türkiye)

Contacts

Primary ContactCevdet Duran

drcduran@gmail.com02762212121

Outcome results